Hospital Volume and Survival After Hepatocellular Carcinoma Diagnosis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hospital Volume and Survival After Hepatocellular Carcinoma Diagnosis
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF GASTROENTEROLOGY
Volume 111, Issue 7, Pages 967-975
Publisher
Springer Nature
Online
2016-05-11
DOI
10.1038/ajg.2016.181
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Global Burden of Cancer 2013
- (2015) Christina Fitzmaurice et al. JAMA Oncology
- Earlier presentation and application of curative treatments in hepatocellular carcinoma
- (2014) Susanna V. Ulahannan et al. HEPATOLOGY
- Treatment of intermediate-stage hepatocellular carcinoma
- (2014) Alejandro Forner et al. Nature Reviews Clinical Oncology
- Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
- (2014) Amit G. Singal et al. PLOS MEDICINE
- Meta-analysis: underutilisation and disparities of treatment among patients with hepatocellular carcinoma in the United States
- (2013) D. Tan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Establishment of a Multidisciplinary Hepatocellular Carcinoma Clinic is Associated with Improved Clinical Outcome
- (2013) Adam C. Yopp et al. ANNALS OF SURGICAL ONCOLOGY
- The Volume Effect in Liver Surgery—A Systematic Review and Meta-analysis
- (2013) Arthur J. Richardson et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Utilization of Hepatocellular Carcinoma Surveillance Among American Patients: A Systematic Review
- (2012) Amit G. Singal et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Rafael Lozano et al. LANCET
- Analysis by Categorizing or Dichotomizing Continuous Variables Is Inadvisable: An Example from the Natural History of Unruptured Aneurysms
- (2011) O. Naggara et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Hepatocellular Carcinoma Confirmation, Treatment, and Survival in Surveillance, Epidemiology, and End Results Registries, 1992-2008
- (2011) Sean F. Altekruse et al. HEPATOLOGY
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy, effectiveness, and comparative effectiveness in liver disease
- (2010) Hashem B. El-Serag et al. HEPATOLOGY
- Quality Improvement for Pancreatic Cancer Care: Is Regionalization a Feasible and Effective Mechanism?
- (2010) Mehul V. Raval et al. Surgical Oncology Clinics of North America
- The Effect of Provider Case Volume on Cancer Mortality: Systematic Review and Meta-Analysis
- (2009) R. L. Gruen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
- (2009) Sean F. Altekruse et al. JOURNAL OF CLINICAL ONCOLOGY
- The Volume-Outcomes Effect in Hepato-Pancreato-Biliary Surgery: Hospital Versus Surgeon Contributions and Specificity of the Relationship
- (2009) Hari Nathan et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Consequences of dichotomization
- (2008) Valerii Fedorov et al. PHARMACEUTICAL STATISTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started